SHARON YAGER: Open Payments
NPI 1659666998 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 48 payments from 12 companies in 2025. Trend: 2023 $877 · 2024 $1,326 · 2025 $1,954
Food & beverage: $1,843Education: $111
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $444 |
| ABBVIE INC. | 12 | $324 |
| Otsuka America Pharmaceutical, Inc. | 5 | $193 |
| Alkermes, Inc. | 4 | $192 |
| Teva Pharmaceuticals USA, Inc. | 6 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $142 |
| E.R. Squibb & Sons, L.L.C. | 2 | $138 |
| Neurocrine BioSciences, Inc. | 1 | $134 |
| Braeburn Inc. | 1 | $88 |
| Lundbeck LLC | 2 | $50 |
Products named: FANAPT, VRAYLAR, REXULTI, VIVITROL, CAPLYTA, COBENFY, INGREZZA, BRIXADI.
Industry payments across NY — which companies pay providers there.
